The global Nuclear Medicine Isotopes market is expected to reach US$ XX Million by 2028, with a CAGR of XX% from 2023 to 2028, based on HNY Research newly published report.
The prime objective of this report is to provide the insights on the post COVID-19 impact which will help market players in this field evaluate their business approaches. Also, this report covers market segmentation by major market verdors, types, applications/end users and geography(North America, East Asia, Europe, South Asia, Southeast Asia, Middle East, Africa, Oceania, South America).
By Market Verdors:
NRG
Cambridge Isotope Laboratories
ANSTO
NTP Radioisotopes
Curium Pharma
JSC Isotope
Polatom
Nordion
IRE
Eckert & Ziegler Strahlen
Shanghai Engineering Research Center
Linde
Center of Molecular Research
SI Science
IDB Holland
LANL
China National Nuclear Corporation
ORNL
NHTC
Urenco
By Types:
Stable Isotopes
Radioisotopes
By Applications:
Nuclear Therapy
Equipment Radioactive Source
Diagnosis
Key Indicators Analysed
Market Players & Competitor Analysis: The report covers the key players of the industry including Company Profile, Product Specifications, Production Capacity/Sales, Revenue, Price and Gross Margin 2017-2028 & Sales with a thorough analysis of the market's competitive landscape and detailed information on vendors and comprehensive details of factors that will challenge the growth of major market vendors.
Global and Regional Market Analysis: The report includes Global & Regional market status and outlook 2017-2028. Further the report provides break down details about each region & countries covered in the report. Identifying its sales, sales volume & revenue forecast. With detailed analysis by types and applications.
Market Trends: Market key trends which include Increased Competition and Continuous Innovations.
Opportunities and Drivers: Identifying the Growing Demands and New Technology
Porters Five Force Analysis: The report provides with the state of competition in industry depending on five basic forces: threat of new entrants, bargaining power of suppliers, bargaining power of buyers, threat of substitute products or services, and existing industry rivalry.
Key Reasons to Purchase
To gain insightful analyses of the market and have comprehensive understanding of the global market and its commercial landscape.
Assess the production processes, major issues, and solutions to mitigate the development risk.
To understand the most affecting driving and restraining forces in the market and its impact in the global market.
Learn about the market strategies that are being adopted by leading respective organizations.
To understand the future outlook and prospects for the market.
Besides the standard structure reports, we also provide custom research according to specific requirements.
Chapter 1 Industry Overview
1.1 Definition
1.2 Assumptions
1.3 Research Scope
1.4 Market Analysis by Regions
1.4.1 North America Market States and Outlook (2023-2028)
1.4.2 East Asia Market States and Outlook (2023-2028)
1.4.3 Europe Market States and Outlook (2023-2028)
1.4.4 South Asia Market States and Outlook (2023-2028)
1.4.5 Southeast Asia Market States and Outlook (2023-2028)
1.4.6 Middle East Market States and Outlook (2023-2028)
1.4.7 Africa Market States and Outlook (2023-2028)
1.4.8 Oceania Market States and Outlook (2023-2028)
1.4.9 South America Market States and Outlook (2023-2028)
1.5 Global Nuclear Medicine Isotopes Market Size Analysis from 2023 to 2028
1.5.1 Global Nuclear Medicine Isotopes Market Size Analysis from 2023 to 2028 by Consumption Volume
1.5.2 Global Nuclear Medicine Isotopes Market Size Analysis from 2023 to 2028 by Value
1.5.3 Global Nuclear Medicine Isotopes Price Trends Analysis from 2023 to 2028
1.6 COVID-19 Outbreak: Nuclear Medicine Isotopes Industry Impact
Chapter 2 Global Nuclear Medicine Isotopes Competition by Types, Applications, and Top Regions and Countries
2.1 Global Nuclear Medicine Isotopes (Volume and Value) by Type
2.1.1 Global Nuclear Medicine Isotopes Consumption and Market Share by Type (2017-2022)
2.1.2 Global Nuclear Medicine Isotopes Revenue and Market Share by Type (2017-2022)
2.2 Global Nuclear Medicine Isotopes (Volume and Value) by Application
2.2.1 Global Nuclear Medicine Isotopes Consumption and Market Share by Application (2017-2022)
2.2.2 Global Nuclear Medicine Isotopes Revenue and Market Share by Application (2017-2022)
2.3 Global Nuclear Medicine Isotopes (Volume and Value) by Regions
2.3.1 Global Nuclear Medicine Isotopes Consumption and Market Share by Regions (2017-2022)
2.3.2 Global Nuclear Medicine Isotopes Revenue and Market Share by Regions (2017-2022)
Chapter 3 Production Market Analysis
3.1 Global Production Market Analysis
3.1.1 2017-2022 Global Capacity, Production, Capacity Utilization Rate, Ex-Factory Price, Revenue, Cost, Gross and Gross Margin Analysis
3.1.2 2017-2022 Major Manufacturers Performance and Market Share
3.2 Regional Production Market Analysis
3.2.1 2017-2022 Regional Market Performance and Market Share
3.2.2 North America Market
3.2.3 East Asia Market
3.2.4 Europe Market
3.2.5 South Asia Market
3.2.6 Southeast Asia Market
3.2.7 Middle East Market
3.2.8 Africa Market
3.2.9 Oceania Market
3.2.10 South America Market
3.2.11 Rest of the World Market
Chapter 4 Global Nuclear Medicine Isotopes Sales, Consumption, Export, Import by Regions (2017-2022)
4.1 Global Nuclear Medicine Isotopes Consumption by Regions (2017-2022)
4.2 North America Nuclear Medicine Isotopes Sales, Consumption, Export, Import (2017-2022)
4.3 East Asia Nuclear Medicine Isotopes Sales, Consumption, Export, Import (2017-2022)
4.4 Europe Nuclear Medicine Isotopes Sales, Consumption, Export, Import (2017-2022)
4.5 South Asia Nuclear Medicine Isotopes Sales, Consumption, Export, Import (2017-2022)
4.6 Southeast Asia Nuclear Medicine Isotopes Sales, Consumption, Export, Import (2017-2022)
4.7 Middle East Nuclear Medicine Isotopes Sales, Consumption, Export, Import (2017-2022)
4.8 Africa Nuclear Medicine Isotopes Sales, Consumption, Export, Import (2017-2022)
4.9 Oceania Nuclear Medicine Isotopes Sales, Consumption, Export, Import (2017-2022)
4.10 South America Nuclear Medicine Isotopes Sales, Consumption, Export, Import (2017-2022)
Chapter 5 North America Nuclear Medicine Isotopes Market Analysis
5.1 North America Nuclear Medicine Isotopes Consumption and Value Analysis
5.1.1 North America Nuclear Medicine Isotopes Market Under COVID-19
5.2 North America Nuclear Medicine Isotopes Consumption Volume by Types
5.3 North America Nuclear Medicine Isotopes Consumption Structure by Application
5.4 North America Nuclear Medicine Isotopes Consumption by Top Countries
5.4.1 United States Nuclear Medicine Isotopes Consumption Volume from 2017 to 2022
5.4.2 Canada Nuclear Medicine Isotopes Consumption Volume from 2017 to 2022
5.4.3 Mexico Nuclear Medicine Isotopes Consumption Volume from 2017 to 2022
Chapter 6 East Asia Nuclear Medicine Isotopes Market Analysis
6.1 East Asia Nuclear Medicine Isotopes Consumption and Value Analysis
6.1.1 East Asia Nuclear Medicine Isotopes Market Under COVID-19
6.2 East Asia Nuclear Medicine Isotopes Consumption Volume by Types
6.3 East Asia Nuclear Medicine Isotopes Consumption Structure by Application
6.4 East Asia Nuclear Medicine Isotopes Consumption by Top Countries
6.4.1 China Nuclear Medicine Isotopes Consumption Volume from 2017 to 2022
6.4.2 Japan Nuclear Medicine Isotopes Consumption Volume from 2017 to 2022
6.4.3 South Korea Nuclear Medicine Isotopes Consumption Volume from 2017 to 2022
Chapter 7 Europe Nuclear Medicine Isotopes Market Analysis
7.1 Europe Nuclear Medicine Isotopes Consumption and Value Analysis
7.1.1 Europe Nuclear Medicine Isotopes Market Under COVID-19
7.2 Europe Nuclear Medicine Isotopes Consumption Volume by Types
7.3 Europe Nuclear Medicine Isotopes Consumption Structure by Application
7.4 Europe Nuclear Medicine Isotopes Consumption by Top Countries
7.4.1 Germany Nuclear Medicine Isotopes Consumption Volume from 2017 to 2022
7.4.2 UK Nuclear Medicine Isotopes Consumption Volume from 2017 to 2022
7.4.3 France Nuclear Medicine Isotopes Consumption Volume from 2017 to 2022
7.4.4 Italy Nuclear Medicine Isotopes Consumption Volume from 2017 to 2022
7.4.5 Russia Nuclear Medicine Isotopes Consumption Volume from 2017 to 2022
7.4.6 Spain Nuclear Medicine Isotopes Consumption Volume from 2017 to 2022
7.4.7 Netherlands Nuclear Medicine Isotopes Consumption Volume from 2017 to 2022
7.4.8 Switzerland Nuclear Medicine Isotopes Consumption Volume from 2017 to 2022
7.4.9 Poland Nuclear Medicine Isotopes Consumption Volume from 2017 to 2022
Chapter 8 South Asia Nuclear Medicine Isotopes Market Analysis
8.1 South Asia Nuclear Medicine Isotopes Consumption and Value Analysis
8.1.1 South Asia Nuclear Medicine Isotopes Market Under COVID-19
8.2 South Asia Nuclear Medicine Isotopes Consumption Volume by Types
8.3 South Asia Nuclear Medicine Isotopes Consumption Structure by Application
8.4 South Asia Nuclear Medicine Isotopes Consumption by Top Countries
8.4.1 India Nuclear Medicine Isotopes Consumption Volume from 2017 to 2022
8.4.2 Pakistan Nuclear Medicine Isotopes Consumption Volume from 2017 to 2022
8.4.3 Bangladesh Nuclear Medicine Isotopes Consumption Volume from 2017 to 2022
Chapter 9 Southeast Asia Nuclear Medicine Isotopes Market Analysis
9.1 Southeast Asia Nuclear Medicine Isotopes Consumption and Value Analysis
9.1.1 Southeast Asia Nuclear Medicine Isotopes Market Under COVID-19
9.2 Southeast Asia Nuclear Medicine Isotopes Consumption Volume by Types
9.3 Southeast Asia Nuclear Medicine Isotopes Consumption Structure by Application
9.4 Southeast Asia Nuclear Medicine Isotopes Consumption by Top Countries
9.4.1 Indonesia Nuclear Medicine Isotopes Consumption Volume from 2017 to 2022
9.4.2 Thailand Nuclear Medicine Isotopes Consumption Volume from 2017 to 2022
9.4.3 Singapore Nuclear Medicine Isotopes Consumption Volume from 2017 to 2022
9.4.4 Malaysia Nuclear Medicine Isotopes Consumption Volume from 2017 to 2022
9.4.5 Philippines Nuclear Medicine Isotopes Consumption Volume from 2017 to 2022
9.4.6 Vietnam Nuclear Medicine Isotopes Consumption Volume from 2017 to 2022
9.4.7 Myanmar Nuclear Medicine Isotopes Consumption Volume from 2017 to 2022
Chapter 10 Middle East Nuclear Medicine Isotopes Market Analysis
10.1 Middle East Nuclear Medicine Isotopes Consumption and Value Analysis
10.1.1 Middle East Nuclear Medicine Isotopes Market Under COVID-19
10.2 Middle East Nuclear Medicine Isotopes Consumption Volume by Types
10.3 Middle East Nuclear Medicine Isotopes Consumption Structure by Application
10.4 Middle East Nuclear Medicine Isotopes Consumption by Top Countries
10.4.1 Turkey Nuclear Medicine Isotopes Consumption Volume from 2017 to 2022
10.4.2 Saudi Arabia Nuclear Medicine Isotopes Consumption Volume from 2017 to 2022
10.4.3 Iran Nuclear Medicine Isotopes Consumption Volume from 2017 to 2022
10.4.4 United Arab Emirates Nuclear Medicine Isotopes Consumption Volume from 2017 to 2022
10.4.5 Israel Nuclear Medicine Isotopes Consumption Volume from 2017 to 2022
10.4.6 Iraq Nuclear Medicine Isotopes Consumption Volume from 2017 to 2022
10.4.7 Qatar Nuclear Medicine Isotopes Consumption Volume from 2017 to 2022
10.4.8 Kuwait Nuclear Medicine Isotopes Consumption Volume from 2017 to 2022
10.4.9 Oman Nuclear Medicine Isotopes Consumption Volume from 2017 to 2022
Chapter 11 Africa Nuclear Medicine Isotopes Market Analysis
11.1 Africa Nuclear Medicine Isotopes Consumption and Value Analysis
11.1.1 Africa Nuclear Medicine Isotopes Market Under COVID-19
11.2 Africa Nuclear Medicine Isotopes Consumption Volume by Types
11.3 Africa Nuclear Medicine Isotopes Consumption Structure by Application
11.4 Africa Nuclear Medicine Isotopes Consumption by Top Countries
11.4.1 Nigeria Nuclear Medicine Isotopes Consumption Volume from 2017 to 2022
11.4.2 South Africa Nuclear Medicine Isotopes Consumption Volume from 2017 to 2022
11.4.3 Egypt Nuclear Medicine Isotopes Consumption Volume from 2017 to 2022
11.4.4 Algeria Nuclear Medicine Isotopes Consumption Volume from 2017 to 2022
11.4.5 Morocco Nuclear Medicine Isotopes Consumption Volume from 2017 to 2022
Chapter 12 Oceania Nuclear Medicine Isotopes Market Analysis
12.1 Oceania Nuclear Medicine Isotopes Consumption and Value Analysis
12.2 Oceania Nuclear Medicine Isotopes Consumption Volume by Types
12.3 Oceania Nuclear Medicine Isotopes Consumption Structure by Application
12.4 Oceania Nuclear Medicine Isotopes Consumption by Top Countries
12.4.1 Australia Nuclear Medicine Isotopes Consumption Volume from 2017 to 2022
12.4.2 New Zealand Nuclear Medicine Isotopes Consumption Volume from 2017 to 2022
Chapter 13 South America Nuclear Medicine Isotopes Market Analysis
13.1 South America Nuclear Medicine Isotopes Consumption and Value Analysis
13.1.1 South America Nuclear Medicine Isotopes Market Under COVID-19
13.2 South America Nuclear Medicine Isotopes Consumption Volume by Types
13.3 South America Nuclear Medicine Isotopes Consumption Structure by Application
13.4 South America Nuclear Medicine Isotopes Consumption Volume by Major Countries
13.4.1 Brazil Nuclear Medicine Isotopes Consumption Volume from 2017 to 2022
13.4.2 Argentina Nuclear Medicine Isotopes Consumption Volume from 2017 to 2022
13.4.3 Columbia Nuclear Medicine Isotopes Consumption Volume from 2017 to 2022
13.4.4 Chile Nuclear Medicine Isotopes Consumption Volume from 2017 to 2022
13.4.5 Venezuela Nuclear Medicine Isotopes Consumption Volume from 2017 to 2022
13.4.6 Peru Nuclear Medicine Isotopes Consumption Volume from 2017 to 2022
13.4.7 Puerto Rico Nuclear Medicine Isotopes Consumption Volume from 2017 to 2022
13.4.8 Ecuador Nuclear Medicine Isotopes Consumption Volume from 2017 to 2022
Chapter 14 Company Profiles and Key Figures in Nuclear Medicine Isotopes Business
14.1 NRG
14.1.1 NRG Company Profile
14.1.2 NRG Nuclear Medicine Isotopes Product Specification
14.1.3 NRG Nuclear Medicine Isotopes Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.2 Cambridge Isotope Laboratories
14.2.1 Cambridge Isotope Laboratories Company Profile
14.2.2 Cambridge Isotope Laboratories Nuclear Medicine Isotopes Product Specification
14.2.3 Cambridge Isotope Laboratories Nuclear Medicine Isotopes Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.3 ANSTO
14.3.1 ANSTO Company Profile
14.3.2 ANSTO Nuclear Medicine Isotopes Product Specification
14.3.3 ANSTO Nuclear Medicine Isotopes Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.4 NTP Radioisotopes
14.4.1 NTP Radioisotopes Company Profile
14.4.2 NTP Radioisotopes Nuclear Medicine Isotopes Product Specification
14.4.3 NTP Radioisotopes Nuclear Medicine Isotopes Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.5 Curium Pharma
14.5.1 Curium Pharma Company Profile
14.5.2 Curium Pharma Nuclear Medicine Isotopes Product Specification
14.5.3 Curium Pharma Nuclear Medicine Isotopes Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.6 JSC Isotope
14.6.1 JSC Isotope Company Profile
14.6.2 JSC Isotope Nuclear Medicine Isotopes Product Specification
14.6.3 JSC Isotope Nuclear Medicine Isotopes Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.7 Polatom
14.7.1 Polatom Company Profile
14.7.2 Polatom Nuclear Medicine Isotopes Product Specification
14.7.3 Polatom Nuclear Medicine Isotopes Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.8 Nordion
14.8.1 Nordion Company Profile
14.8.2 Nordion Nuclear Medicine Isotopes Product Specification
14.8.3 Nordion Nuclear Medicine Isotopes Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.9 IRE
14.9.1 IRE Company Profile
14.9.2 IRE Nuclear Medicine Isotopes Product Specification
14.9.3 IRE Nuclear Medicine Isotopes Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.10 Eckert & Ziegler Strahlen
14.10.1 Eckert & Ziegler Strahlen Company Profile
14.10.2 Eckert & Ziegler Strahlen Nuclear Medicine Isotopes Product Specification
14.10.3 Eckert & Ziegler Strahlen Nuclear Medicine Isotopes Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.11 Shanghai Engineering Research Center
14.11.1 Shanghai Engineering Research Center Company Profile
14.11.2 Shanghai Engineering Research Center Nuclear Medicine Isotopes Product Specification
14.11.3 Shanghai Engineering Research Center Nuclear Medicine Isotopes Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.12 Linde
14.12.1 Linde Company Profile
14.12.2 Linde Nuclear Medicine Isotopes Product Specification
14.12.3 Linde Nuclear Medicine Isotopes Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.13 Center of Molecular Research
14.13.1 Center of Molecular Research Company Profile
14.13.2 Center of Molecular Research Nuclear Medicine Isotopes Product Specification
14.13.3 Center of Molecular Research Nuclear Medicine Isotopes Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.14 SI Science
14.14.1 SI Science Company Profile
14.14.2 SI Science Nuclear Medicine Isotopes Product Specification
14.14.3 SI Science Nuclear Medicine Isotopes Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.15 IDB Holland
14.15.1 IDB Holland Company Profile
14.15.2 IDB Holland Nuclear Medicine Isotopes Product Specification
14.15.3 IDB Holland Nuclear Medicine Isotopes Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.16 LANL
14.16.1 LANL Company Profile
14.16.2 LANL Nuclear Medicine Isotopes Product Specification
14.16.3 LANL Nuclear Medicine Isotopes Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.17 China National Nuclear Corporation
14.17.1 China National Nuclear Corporation Company Profile
14.17.2 China National Nuclear Corporation Nuclear Medicine Isotopes Product Specification
14.17.3 China National Nuclear Corporation Nuclear Medicine Isotopes Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.18 ORNL
14.18.1 ORNL Company Profile
14.18.2 ORNL Nuclear Medicine Isotopes Product Specification
14.18.3 ORNL Nuclear Medicine Isotopes Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.19 NHTC
14.19.1 NHTC Company Profile
14.19.2 NHTC Nuclear Medicine Isotopes Product Specification
14.19.3 NHTC Nuclear Medicine Isotopes Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.20 Urenco
14.20.1 Urenco Company Profile
14.20.2 Urenco Nuclear Medicine Isotopes Product Specification
14.20.3 Urenco Nuclear Medicine Isotopes Production Capacity, Revenue, Price and Gross Margin (2017-2022)
Chapter 15 Global Nuclear Medicine Isotopes Market Forecast (2023-2028)
15.1 Global Nuclear Medicine Isotopes Consumption Volume, Revenue and Price Forecast (2023-2028)
15.1.1 Global Nuclear Medicine Isotopes Consumption Volume and Growth Rate Forecast (2023-2028)
15.1.2 Global Nuclear Medicine Isotopes Value and Growth Rate Forecast (2023-2028)
15.2 Global Nuclear Medicine Isotopes Consumption Volume, Value and Growth Rate Forecast by Region (2023-2028)
15.2.1 Global Nuclear Medicine Isotopes Consumption Volume and Growth Rate Forecast by Regions (2023-2028)
15.2.2 Global Nuclear Medicine Isotopes Value and Growth Rate Forecast by Regions (2023-2028)
15.2.3 North America Nuclear Medicine Isotopes Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
15.2.4 East Asia Nuclear Medicine Isotopes Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
15.2.5 Europe Nuclear Medicine Isotopes Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
15.2.6 South Asia Nuclear Medicine Isotopes Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
15.2.7 Southeast Asia Nuclear Medicine Isotopes Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
15.2.8 Middle East Nuclear Medicine Isotopes Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
15.2.9 Africa Nuclear Medicine Isotopes Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
15.2.10 Oceania Nuclear Medicine Isotopes Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
15.2.11 South America Nuclear Medicine Isotopes Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
15.3 Global Nuclear Medicine Isotopes Consumption Volume, Revenue and Price Forecast by Type (2023-2028)
15.3.1 Global Nuclear Medicine Isotopes Consumption Forecast by Type (2023-2028)
15.3.2 Global Nuclear Medicine Isotopes Revenue Forecast by Type (2023-2028)
15.3.3 Global Nuclear Medicine Isotopes Price Forecast by Type (2023-2028)
15.4 Global Nuclear Medicine Isotopes Consumption Volume Forecast by Application (2023-2028)
15.5 Nuclear Medicine Isotopes Market Forecast Under COVID-19
Chapter 16 Conclusions
Research Methodology
| Price : US$ 3500 |
Date : Nov 2024 |
| Category : Services |
Pages : 139 |
Request Sample 
Request Discount 
Inquire Before Buy
